In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data

The ongoing global pandemic of coronavirus disease 2019 (COVID-19) continues to affect a growing number of populations in different parts of the world. In the current situation, drug repurposing is a viable strategy to combat COVID-19. The drugs targeting the host receptors that interact with SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Shaoli, Camphausen, Kevin, Shankavaram, Uma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362896/
https://www.ncbi.nlm.nih.gov/pubmed/32702730
http://dx.doi.org/10.21203/rs.3.rs-39128/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362896/
https://www.ncbi.nlm.nih.gov/pubmed/32702730
http://dx.doi.org/10.21203/rs.3.rs-39128/v1

Ejemplares similares